SuperworthCumberland Pharmaceuticals shares outstanding CPIX
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 15M
- On a year earlier
- +0.1%
- more shares
Cumberland Pharmaceuticals had 15M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 14.6M | +4% |
| FY2024 | 14M | −1% |
| FY2023 | 14.2M | −2% |
| FY2022 | 14.4M | −3% |
| FY2021 | 14.8M | −2% |
| FY2020 | 15M | −1% |
| FY2019 | 15.2M | −2% |
| FY2018 | 15.5M | −1% |
| FY2017 | 15.7M | −3% |
| FY2016 | 16.1M | −4% |
| FY2015 | 16.8M | −5% |
| FY2014 | 17.6M | −2% |
| FY2013 | 18.1M | −6% |
| FY2012 | 19.2M | −5% |
| FY2011 | 20.3M | −2% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 15M | +0% | |
| Q1 FY26 | 15M | −2% | |
| Q4 FY25 | 14.6M | +4% | |
| Q3 FY25 | 15M | +6% | |
| Q2 FY25 | 15M | +6% | |
| Q1 FY25 | 15.3M | +8% | |
| Q4 FY24 | 14M | −1% | |
| Q3 FY24 | 14.1M | −2% | |
| Q2 FY24 | 14.1M | −3% | |
| Q1 FY24 | 14.1M | −3% | |
| Q4 FY23 | 14.2M | −2% | |
| Q3 FY23 | 14.3M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cumberland Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.